Switch theme
Sign up to access all valuation multiples
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
2008
37.0K+
LTM Revenue $15.6B
LTM EBITDA $3.6B
$22.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Otsuka Holdings has a last 12-month revenue of $15.6B and a last 12-month EBITDA of $3.6B.
In the most recent fiscal year, Otsuka Holdings achieved revenue of $15.5B and an EBITDA of $3.0B.
Otsuka Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Otsuka Holdings valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $13.4B | $15.5B | XXX | XXX | XXX |
| Gross Profit | $7.8B | $9.4B | XXX | XXX | XXX |
| Gross Margin | 58% | 60% | XXX | XXX | XXX |
| EBITDA | $1.6B | $3.0B | XXX | XXX | XXX |
| EBITDA Margin | 12% | 19% | XXX | XXX | XXX |
| Net Profit | $891M | $808M | XXX | XXX | XXX |
| Net Margin | 7% | 5% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Otsuka Holdings's stock price is JPY 6803 (or $45).
Otsuka Holdings has current market cap of JPY 3.65T (or $24.3B), and EV of JPY 3.39T (or $22.5B).
See Otsuka Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22.5B | $24.3B | XXX | XXX | XXX | XXX | $4.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Otsuka Holdings has market cap of $24.3B and EV of $22.5B.
Otsuka Holdings's trades at 1.4x LTM EV/Revenue multiple, and 6.3x LTM EBITDA.
Analysts estimate Otsuka Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Otsuka Holdings and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $22.5B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 7.5x | XXX | XXX | XXX |
| P/E | 10.6x | XXX | XXX | XXX |
| P/E/Growth | -1.0x | XXX | XXX | XXX |
| EV/FCF | 15.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOtsuka Holdings's NTM/LTM revenue growth is 2%
Otsuka Holdings's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Otsuka Holdings's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Otsuka Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Otsuka Holdings and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 83% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 22% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 41% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Otsuka Holdings acquired XXX companies to date.
Last acquisition by Otsuka Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Otsuka Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Otsuka Holdings founded? | Otsuka Holdings was founded in 2008. |
| Where is Otsuka Holdings headquartered? | Otsuka Holdings is headquartered in Japan. |
| How many employees does Otsuka Holdings have? | As of today, Otsuka Holdings has 37.0K+ employees. |
| Who is the CEO of Otsuka Holdings? | Otsuka Holdings's CEO is Mr. Tatsuo Higuchi. |
| Is Otsuka Holdings publicy listed? | Yes, Otsuka Holdings is a public company listed on TKS. |
| What is the stock symbol of Otsuka Holdings? | Otsuka Holdings trades under 4578 ticker. |
| When did Otsuka Holdings go public? | Otsuka Holdings went public in 2010. |
| Who are competitors of Otsuka Holdings? | Similar companies to Otsuka Holdings include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Otsuka Holdings? | Otsuka Holdings's current market cap is $24.3B |
| What is the current revenue of Otsuka Holdings? | Otsuka Holdings's last 12-month revenue is $15.6B. |
| What is the current EBITDA of Otsuka Holdings? | Otsuka Holdings's last 12-month EBITDA is $3.6B. |
| What is the current EV/Revenue multiple of Otsuka Holdings? | Current revenue multiple of Otsuka Holdings is 1.4x. |
| What is the current EV/EBITDA multiple of Otsuka Holdings? | Current EBITDA multiple of Otsuka Holdings is 6.3x. |
| What is the current revenue growth of Otsuka Holdings? | Otsuka Holdings revenue growth between 2023 and 2024 was 15%. |
| Is Otsuka Holdings profitable? | Yes, Otsuka Holdings is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
